首页 › 基金 › Trails Edge Capital Partners, LP › TRAX
Trails Edge Capital Partners, LP 对 TRAX 的持仓历史
FIRST TRACKS BIOTHERAPEUTICS · 医疗保健
Trails Edge Capital Partners, LP 在 Q3 2026 的 13F 申报中披露持有 TRAX(FIRST TRACKS BIOTHERAPEUTICS)814,000 股,市值约 US$28.8M,约占其申报组合的 4.15%,在其申报持仓中市值排名第 9 位。 Trails Edge Capital Partners, LP 最近 2 个申报季度中有 2 个季度披露了 TRAX 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Trails Edge Capital Partners, LP 对 TRAX 的持仓演变
Trails Edge Capital Partners, LP 于 Q2 2026 首次披露 TRAX 持仓:1,514,000 股(约 US$30.5M)。 在 2 次申报中,Trails Edge Capital Partners, LP 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 814,000 股、市值约 US$28.8M,环比减持 -700,000 股。。 持仓曾出现大幅变动:Q3 2026 减持约 46% (随后一个季度股价上涨 33%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.51M | $30.46M | 新进 |
| Q3 2026 | 814.00K | $28.85M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TRAX 与 13F 数据
TRAX(FIRST TRACKS BIOTHERAPEUTICS)属于医疗保健行业。我们追踪的基金中还有 181 只申报持有 TRAX,申报仓位最大的包括:EcoR1 Capital, LLC (US$112.5M), TCG Crossover Management, LLC (US$102.6M), Affinity Asset Advisors, LLC (US$73.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TRAX 的基金
- EcoR1 Capital, LLC 3.17M 股 · $112.50M · Q3 2026
- TCG Crossover Management, LLC 2.90M 股 · $102.61M · Q3 2026
- Affinity Asset Advisors, LLC 2.08M 股 · $73.72M · Q3 2026
- Sanofi 821.92K 股 · $29.13M · Q3 2026
- STEMPOINT CAPITAL LP 649.92K 股 · $23.03M · Q3 2026
- 683 Capital Management, LLC 600.00K 股 · $21.26M · Q3 2026
- Vestal Point Capital, LP 1.01M 股 · $20.38M · Q2 2026
- Sofinnova Investments, Inc. 383.59K 股 · $13.59M · Q3 2026
- Palo Alto Investors LP 603.49K 股 · $12.14M · Q2 2026
- Ally Bridge Group (NY) LLC 284.29K 股 · $5.72M · Q2 2026
- Opaleye Management Inc. 65.00K 股 · $1.31M · Q2 2026
更多关于 Trails Edge Capital Partners, LP
常见问题
How long has Trails Edge Capital Partners, LP held TRAX?
Trails Edge Capital Partners, LP has disclosed TRAX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Trails Edge Capital Partners, LP's current position in TRAX?
As of Q3 2026, Trails Edge Capital Partners, LP holds 814.00K shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS), valued at $28.85M, representing 4.15% of its reported portfolio and ranking #9.
Has Trails Edge Capital Partners, LP been buying or selling TRAX?
In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP reduced its position in TRAX.
Which other funds hold TRAX?
Other major institutional holders of TRAX include EcoR1 Capital, LLC, TCG Crossover Management, LLC, Affinity Asset Advisors, LLC, among 181 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.